Appointment of Strategic Adviser – Somfit® US Pharmacy and Consumer Program

Compumedics Limited (ASX: CMP) has appointed Mr Syed Husain, Managing Partner of Red Brook Advisors and former Head of Corporate Development and M&A at a Fortune 5 US healthcare company, as strategic adviser to lead its Somfit® US pharmacy and consumer program.

The program is evaluating partnership, licensing, distribution and strategic investment opportunities for Somfit® and the NEXUS 360® platform with US pharmacy, consumer-health and related healthcare groups. It is the first of the Board’s dedicated deal-maker appointments across its five value-realisation programs, with the Board expecting to make two to three further strategic investment or investment banking appointments by the end of the March 2027 quarter. This approach is designed to realise value for shareholders through partnerships or strategic investment rather than by issuing new shares.

Mr Husain is a registered pharmacist and healthcare M&A executive with more than 30 years’ experience. Over almost 20 years at a Fortune 5 US healthcare company he rose to Head of Corporate Development and M&A, and he later founded the healthcare and pharmacy practice at a boutique Wall Street investment bank. He has led Red Brook Advisors since 2023.

About Compumedics Limited

Compumedics Limited [ASX: CMP] is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The company owns US based Neuroscan and Germany based DWL Elektronische GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including the Americas, Australia and Asia Pacific, Europe and the Middle East.

Executive Chairman Dr David Burton founded Compumedics in 1987. In the same year the company successfully designed and installed the first Australian, fully computerised sleep clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets.

Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards, including Australia’s Exporter of the Year, and has been recognised as a Top 100 Innovator by both German and Australian governments.

For further information please contact:

Dr David Burton
Executive Chairman, CEO
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399      

Troy Lamb
Chief Financial Officer and Company Secretary
Phone: + 61 3 8420 7300
Fax: +61 3 8420 7399

This announcement has been authorised for release by the Board of Directors of Compumedics Limited.